GlassScriptPhysician profile
Philip M Fish
NPI 1841782307
$4,785.46
in general payments reported to CMS, 2019-2025
34 companies · $1,703 in 2025
The $1,703 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.22 · 2021: $106 · 2022: $48.27 · 2023: $1,609 · 2024: $1,268 · 2025: $1,703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,490 · Travel and Lodging: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,490.35 |
| Travel and Lodging | $1,090.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $746.38 | 2023 | Cook |
| Procept Biorobotics Corporation | $639.66 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Cook Incorporated | $484.90 | 2023 | Fiber Dust |
| Boston Scientific Corporation | $437.60 | 2019-2025 | Lithoclast, Ams 700 Cxr Rte Kit, Spaceoar Vue System - 10ml |
| Dendreon Pharmaceuticals LLC | $363.53 | 2024-2025 | Provenge |
| Sumitomo Pharma America, INC. | $321.58 | 2024-2025 | Gemtesa, Orgovyx |
| Agiliti Health, INC. | $321.30 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion, Coloplast Tfl Drive Laser |
| Accord Healthcare, INC. | $271.84 | 2024-2025 | |
| Janssen Biotech, INC. | $132.97 | 2024-2025 | Erleada, Akeega |
| Pfizer INC. | $102.97 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $92.81 | 2024-2025 | Adstiladrin |
| Calyxo, INC. | $84.90 | 2025 | Cvac Aspiration System |
| Novartis Pharmaceuticals Corporation | $77.92 | 2024-2025 | |
| Medtronic, INC. | $63.92 | 2023-2025 | Interstim |
| Progenics Pharmaceuticals, INC. | $57.94 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $52.39 | 2024 | |
| Endo Pharmaceuticals INC. | $49.73 | 2023-2024 | Xiaflex, Aveed |
| Tolmar, INC. | $47.04 | 2023-2025 | Eligard, Jatenzo |
| Convatec INC. | $46.18 | 2023 | |
| Cycle Pharmaceuticals INC | $40.89 | 2025 | Venxxiva |
| Olympus America INC. | $35.21 | 2025 | Itind System |
| Laborie Medical Technologies Corp. | $34.10 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $33.44 | 2024-2025 | Xiaflex |
| Merck Sharp & Dohme LLC | $31.87 | 2024 | Keytruda, Welireg |
| Teleflex LLC | $30.78 | 2024 | Urolift |
| Verity Pharmaceuticals INC. | $28.20 | 2025 | Trelstar |
| Immunitybio, INC. | $27.98 | 2025 | |
| Galvanize Therapeutics, INC | $21.52 | 2025 | Aliya System |
| Telix Pharmaceuticals | $21.47 | 2024 | Illuccix |
| Coloplast Corp | $21.44 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.22 | 2023 | |
| Halozyme INC | $16.50 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $14.78 | 2025 | |
| Abbvie INC. | $13.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Fish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.